Impel Pharmaceuticals Inc.
IMPL · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$106 | -$77 | -$46 | -$42 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $2 | $0 | $0 |
| Stock-Based Comp. | $5 | $3 | $4 | $1 |
| Change in WC | -$13 | $2 | $2 | $3 |
| Other Non-Cash | $19 | $2 | $0 | $1 |
| Operating Cash Flow | -$94 | -$66 | -$39 | -$36 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$2 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$0 | -$2 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $67 | $148 | $11 | $0 |
| Financing Cash Flow | $67 | $148 | $11 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$28 | $81 | -$30 | -$38 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88 | $7 | $37 | $75 |
| End Cash | $61 | $88 | $7 | $37 |
| Free Cash Flow | -$95 | -$67 | -$41 | -$38 |